Answers are grounded in this paper and cite their sources.
This research shows that N1 VLP vaccination confers protection against influenza B virus in mice, suggesting a promising vaccine strategy.
These findings indicate that the N1 VLP vaccine induces measurable immune responses, confers protection against heterologous Victoria-lineage influenza B virus challenge in mice, and is well-tolerated.
No takes yet. Share an insight, caveat, or question.
Eom et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: